Cherry Picking
2015
•
‘‘There is an evil tendency underlying all our technology – the tendency to do what is
reasonable even when it isn’t any good’’
•
These new opportunities provide hope for our prostate cancer (PCa) men, but is it
beneficial?
•
The primary study endpoint of distant progression-free survival reported a 21 mo
median with a 36 mo follow-up. It is pleasing to note that nearly 39% were free of
distant progression and delay to androgen deprivation therapy was 28 mo.
•
“This metastasis- directed strategy does represent a realistic
opportunity for our PCa men and is best addressed within
randomised studies.
”
